ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 198 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,047,000 | +139.0% | 179,162 | +238.4% | 0.01% | +200.0% |
| Q2 2015 | $438,000 | -85.2% | 52,947 | -85.2% | 0.00% | -88.2% |
| Q1 2015 | $2,950,000 | +107.0% | 358,053 | +72.6% | 0.02% | +112.5% |
| Q4 2014 | $1,425,000 | +19.7% | 207,400 | -5.9% | 0.01% | 0.0% |
| Q3 2014 | $1,190,000 | -42.8% | 220,320 | -32.5% | 0.01% | -55.6% |
| Q2 2014 | $2,079,000 | +12.5% | 326,470 | +42.4% | 0.02% | 0.0% |
| Q1 2014 | $1,848,000 | -57.4% | 229,268 | -64.0% | 0.02% | -33.3% |
| Q4 2013 | $4,342,000 | -18.5% | 636,600 | +120.0% | 0.03% | -48.1% |
| Q3 2013 | $5,325,000 | +123.8% | 289,400 | +112.9% | 0.05% | +92.6% |
| Q2 2013 | $2,379,000 | – | 135,930 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |